JPRN-UMIN000008452已完成1 期
Phase 1 study of chemoradiation with bevacizumab as preoperative treatment in locally advanced rectal cancer. - Phase 1 study of chemoradiation with bevacizumab as preoperative treatment in locally advanced rectal cancer.
Department of Gastrointestinal and Paediatric Surgery Division of Reparative Medicine Institute of Life Sciences Mie University Graduate School of Medicine0 个研究点目标入组 12 人开始时间: 2012年7月18日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Previous history of drug-induced allergy 2)Pregnant or lactating and woman with childbearing potential who lacked effective contraception 3)Man who lacked effective contraception 4)Evidence of thronbosis and need anti-coagulability drugs 5)With uncontrolled renal failure 6)With uncontrolled hypertention 7)With uncontrolled heart disease 8)With severe plumonary disease(intestinal pneumotitis, pulmonary fibrosis) 9)With gastrointestinal bleeding,obstruction, perforation 10) With active inflammatory bowel disease 11)With active infection 12)With brain metastasis 13)Synchronous or metachronous malignancy 14) Patient who received surgery within 28 days at registration 15) Any other cases who are regard as inadequate for study enrollment by the investigator
研究者
相似试验
招募中
不适用
Phase II Study of bevacizumab combined with chemotherapy (paclitaxel/carboplatin) as postoperative adjuvant therapy for cervical cancerCervical cancerJPRN-UMIN000029306niversity of the Ryukyus63
已完成
1 期
Phase I trial of Bevacizumab and S-1 chemotherapy for patients with previously treated advanced non-small cell lung cancerPreviously treated non-small cell lung cancerJPRN-UMIN000008613Thoracic Medical Oncology Cancer Institute Hospital of Japanese Foundation for Cancer Research15
已完成
1 期
Phase I trial of combined chemotherapy of bevacizumab, panitumumab and irinotecan as 3rd-line chemotherapy in chmotherapy-refractory metastatic colorectal cancer.Colorectal cancerJPRN-UMIN000009362ational Cancer Center Hospital, Tokyo, Japan.12
已完成
1 期
Phase I study of neo-adjuvant chemoradiation therapy for newly diagnosed malignant astrocytomasmalignant astyrocytomasJPRN-UMIN000015566Chiba Cancer Center20
进行中（未招募）
不适用
Phase I-II Study of the Combination of Bevacizumab (rhuMAb VEGF) and Erlotinib (EGFR TKI) plus Oxaliplatin and Capecitabine (XELOX) in Patients with Metastatic Colorectal Cancer: XELOX-TARAV study - XELOX-TARAVEUCTR2005-005548-21-ITCONSORZIO ONCOTECH